Variant report
Variant | nsv965632 |
---|---|
Chromosome Location | chr6:27821900-27825669 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-HIST1H2BN-1 | chr6:27821498-27822512 | NONHSAT108411 |
2 | lnc-HIST1H2BN-1 | chr6:27823457-27823582 | NONHSAT108411 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139641978 | chr6:27821916-27821917 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs115519675 | chr6:27821942-27821943 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs565541985 | chr6:27822012-27822013 | Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs531251869 | chr6:27822048-27822049 | Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs144268175 | chr6:27822132-27822133 | Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs73386626 | chr6:27822165-27822166 | Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs181769328 | chr6:27822168-27822169 | Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs546706471 | chr6:27822175-27822176 | Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs145220758 | chr6:27822182-27822183 | Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs374879312 | chr6:27822347-27822348 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs551976004 | chr6:27822375-27822376 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs371097876 | chr6:27822526-27822527 | Weak transcription Enhancers Flanking Active TSS Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs186290953 | chr6:27822644-27822645 | Weak transcription Enhancers Flanking Active TSS Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190314481 | chr6:27822688-27822689 | Weak transcription Enhancers Flanking Active TSS Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556925674 | chr6:27822695-27822696 | Weak transcription Enhancers Flanking Active TSS Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567698341 | chr6:27822753-27822754 | Weak transcription Enhancers Flanking Active TSS Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536326985 | chr6:27822789-27822790 | Weak transcription Enhancers Flanking Active TSS Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553466094 | chr6:27822803-27822804 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs578154099 | chr6:27822871-27822872 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573269668 | chr6:27822875-27822876 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537853117 | chr6:27822913-27822914 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559196404 | chr6:27822929-27822930 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372122070 | chr6:27823015-27823016 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373199461 | chr6:27823016-27823017 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1058975 | chr6:27823053-27823054 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs151223612 | chr6:27823073-27823074 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183050088 | chr6:27823138-27823139 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560848390 | chr6:27823149-27823150 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572424951 | chr6:27823156-27823157 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529729850 | chr6:27823203-27823204 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140372054 | chr6:27823231-27823232 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188227108 | chr6:27823234-27823235 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs556480313 | chr6:27823304-27823305 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375836404 | chr6:27823342-27823343 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373702261 | chr6:27823430-27823431 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532111063 | chr6:27823447-27823448 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540369415 | chr6:27823449-27823450 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551914540 | chr6:27823460-27823461 | Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs562382493 | chr6:27823556-27823557 | Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs191323771 | chr6:27823603-27823604 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548105436 | chr6:27823634-27823635 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567536163 | chr6:27823641-27823642 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146987885 | chr6:27823705-27823706 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546697689 | chr6:27823801-27823802 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147611009 | chr6:27823816-27823817 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539143584 | chr6:27823839-27823840 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142096374 | chr6:27823903-27823904 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369265290 | chr6:27823937-27823938 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs542202020 | chr6:27823960-27823961 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182751000 | chr6:27823962-27823963 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:27808000-27822400 | Weak transcription | Primary B cells from peripheral blood | blood |
2 | chr6:27808000-27831800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr6:27808200-27830600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:27813800-27822200 | Weak transcription | Primary B cells from cord blood | blood |
5 | chr6:27814000-27822200 | Weak transcription | GM12878-XiMat | blood |
6 | chr6:27820600-27822000 | Weak transcription | K562 | blood |
7 | chr6:27822000-27824000 | Strong transcription | K562 | blood |
8 | chr6:27822200-27822400 | Enhancers | GM12878-XiMat | blood |
9 | chr6:27822200-27822800 | Enhancers | Primary B cells from cord blood | blood |
10 | chr6:27822400-27822800 | Enhancers | Primary B cells from peripheral blood | blood |
11 | chr6:27822400-27822800 | Flanking Active TSS | GM12878-XiMat | blood |
12 | chr6:27822800-27831800 | Weak transcription | Primary B cells from peripheral blood | blood |
13 | chr6:27823600-27824000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr6:27824000-27828400 | Weak transcription | K562 | blood |
15 | chr6:27824000-27831800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |